RESOLIAN ANALYTICAL SCIENCES
LIVE

Serial Number

97796240

Owner

ALLIANCE PHARMA INC.

Attorney

Christopher D. Olszyk, Jr.

First Use Date

May 17, 2023

Filing Date

Feb 15, 2023

Add to watchlist:

No watchlists yet
View on USPTO

RESOLIAN ANALYTICAL SCIENCES Trademark

Serial Number: 97796240 • Registration: 7410179

RESOLIAN ANALYTICAL SCIENCES is a trademark filed by ALLIANCE PHARMA INC. on February 15, 2023. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

ALLIANCE PHARMA INC. (19 trademarks)

11000 REGENCY PKWY
CARY, NC 27518

Entity Type: 03

Trademark Details

Filing Date

February 15, 2023

Registration Date

June 4, 2024

First Use Anywhere

May 17, 2023

First Use in Commerce

May 17, 2023

Published for Opposition

January 9, 2024

Goods & Services

Laboratory testing services in clinical research and clinical trials of innovator and generic medicines in the pharmaceutical and biotechnology fields; Research and development in the fields of bioanalysis, immunoassay development, bioanalytical assay validation and testing, biomarker studies, drug metabolism, and pharmacokinetic testing; Pharmaceutical research and development services; Chemical, bioanalytical, biological and biotechnology research services; Research and development in the pharmaceutical and biotechnology fields; Research and development of vaccines and medicines; Pharmaceutical drug development services; Scientific testing in the fields of oncology, neurology, gastroenterology, immunology, endocrinology, gene therapy, infectious disease, rare and orphan diseases, cardiovascular disease, metabolic disease, central nervous system, ophthalmology, and respiratory diseases, for medical and pharmaceutical research purposes; Drug and chemical materials analysis services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of pharmaceutical, biopharmaceutical, biotechnology and medical device development; Scientific analytical laboratory services; Good Manufacturing Practices (GMP) laboratory and stability testing and analytical services in the fields of pharmaceutical drug, pharmaceutical excipient, and consumer healthcare chemical development; Chemistry, Manufacturing, and Controls (CMC) laboratory and stability testing and analytical services in the fields of pharmaceutical drug, pharmaceutical excipient, and consumer healthcare chemical development; Analytical services, namely, providing Good Laboratory Practices (GLP) testing and quality assurance services to assess clinical performance in the field of therapeutic drug evaluation and development

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 4, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 4, 2024 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 30, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 30, 2024 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Apr 19, 2024 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 19, 2024 AITU
USE AMENDMENT FILED
Apr 1, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Apr 1, 2024 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 5, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 9, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jan 9, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 20, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 2, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 29, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 28, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 28, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 14, 2023 GNRN
NON-FINAL ACTION E-MAILED
Nov 14, 2023 GNRT
NON-FINAL ACTION WRITTEN
Nov 14, 2023 CNRT
ASSIGNED TO EXAMINER
Nov 14, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 6, 2023 NWOS
NEW APPLICATION ENTERED
Feb 18, 2023 NWAP